Top 11 triumvira.com competitors & alternatives
[Triumvira Immunologics - Triumvira Immunologics | Car-T, TCR, TAC Therapies and Immunotherapy ... Read more »]
triumvira.com competitors and alternatives
Top 11 triumvira.com competitors and alternatives are ranked by similar search terms, traffic and worth.
triumvira.com's top 5 competitors are: obio.ca with 2,500 daily traffic and 21,400 estimated worth, medigene.com with 130 daily traffic and 17,700 estimated worth, pegsummiteurope.com with 4,000 daily traffic and 12,400 estimated worth, adaptimmune.com with 200 daily traffic and 10,800 estimated worth, zymeworks.com with 170 daily traffic and 10,300 estimated worth.
obio.ca
Ontario Bioscience Innovation Organization - Furthering the development and commercialization of Ontario's human health technology
OBIO® engages in strategy and policy development, advocacy and government
relations to further the development and commercialization of Ontario’s
human health technologies.
Daily Traffic: 2,500
Website Worth: $ 21,400
medigene.com
Medigene - Home
Medigene focuses on clinical research and development of novel drugs against cancer and autoimmune diseases.
Daily Traffic: 130
Website Worth: $ 17,700
pegsummiteurope.com
PEGS Europe | Protein & Antibody Engineering Summit | 5-7 November 2024
Discover Pegsummit Europe, your premier partner for innovative meeting and event solutions across Europe. Experience seamless event planning and management tailored to your needs.
Daily Traffic: 4,000
Website Worth: $ 12,400
adaptimmune.com
Adaptimmune Therapeutics plc (ADAP)
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Daily Traffic: 200
Website Worth: $ 10,800
zymeworks.com
Making a Meaningful Difference — Zymeworks
Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases
Daily Traffic: 170
Website Worth: $ 10,300
ontariogenomics.ca
Homepage - Ontario Genomics
Ontario Genomics’ leads the application of genomics-based solutions to drive economic growth and improve quality of life for Ontario.
Daily Traffic: 20
Website Worth: $ 10,200
tcr2.com
TCR² Therapeutics
TCR² is developing a new generation of T cell therapies for patients
suffering from cancer. Our proprietary TRuC™ (TCR Fusion Construct) T cells
harness the natural T cell receptor complex to recognize and kill cancer
cells using the full power of T cell signaling pathways independent of HLA.
Daily Traffic: 0
Website Worth: $ 7,300
car-tcr-summit.com
10th CAR-TCR Summit | Leading Cell Therapy Conference
The 6th CAR-TCR Summit 2021 is dedicated to the development of safe, clinically effective & globally accessible CAR & TCR based cell immunotherapies inoncology & beyond
Daily Traffic: 0
Website Worth: $ 4,000
eurekatherapeutics.com
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like triumvira.com